Open Access Editorial Article ID: OJPCH-1-103

    Improving Pediatric Care for Epileptic Children - What Does the Pediatrician Needs to Know about Antiepileptic Drugs?

    Khaled Saad*

    While sharing a common property of suppressing seizures, anti epileptic drugs (AEDs) have many different pharmacological profiles that are relevant when selecting and prescribing these agents in children with epilepsy and other conditions. This includes pharmacokinetic properties, drug-drug interactions, and side effect profiles and toxicities [1]. Over the past two decades, the number of AEDs has more than doubled. Unlike some of the former AEDs such as phenobarbital and phenytoin, many of the currently AEDs have simple pharmacokinetics and less side effects on liver. This explains into a generally lower rate of side effects, reduced need for serum monitoring, once or twice daily dosing and fewer drug-drug interactions. Despite these advantages, however, there are few data to suggest significant differences in effectiveness among the older AEDs [1,2].


    Published on: Nov 24, 2015 Pages: 9-10

    Full Text PDF Full Text HTML DOI: 10.17352/ojpch.000003
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat


    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on OJPCH

    Google Reviews 11